prof. dr. P. (Peter) Olinga

Professor of Translational Biopharmaceutics


Postal address:
A Deusinglaan1
Gebouw 3213, ruimte 0205
9713 AV
Phone: +31 50 363 8373Fax: +31 50 363 2500
  1. The Citrullinated and MMP-degraded Vimentin Biomarker (VICM) Predicts Early Response to Anti-TNFα Treatment in Crohn's Disease

    Mortensen, J. H., van Haaften, W. T., Karsdal, M. A., Bay-Jensen, A-C., Olinga, P., Grønbæk, H., Hvas, C. L., Manon-Jensen, T., Dijkstra, G. & Dige, A., 14-Apr-2020, In : Journal of clinical gastroenterology.

    Research output: Contribution to journalArticleAcademicpeer-review

  2. Survival and cellular heterogeneity of epithelium in cultured mouse and rat precision-cut intestinal slices

    Biel, C., Bigaeva, E., Hesse, M., Bomers, J. J. M., van Summeren, K., Teunis, M. A. T., Vaessen, S., Ten Klooster, J. P. & Olinga, P., Dec-2020, In : Toxicology in Vitro. 69, 104974.

    Research output: Contribution to journalArticleAcademicpeer-review

  3. Host microbiota dictates the proinflammatory impact of LPS in the murine liver

    Suriguga, S., Luangmonkong, T., Mutsaers, H. A. M., Groothuis, G. M. M. & Olinga, P., Sep-2020, In : Toxicology in Vitro. 67, 7 p., 104920.

    Research output: Contribution to journalArticleAcademicpeer-review

  4. Osteoprotegerin Is more than a Possible Serum Marker in Liver Fibrosis: A Study into Its Function in Human and Murine Liver

    Adhyatmika, A., Beljaars, L., Putri, K. S. S., Habibie, H., Boorsma, C. E., Reker-Smit, C., Luangmonkong, T., Guney, B., Haak, A., Mangnus, K. A., Post, E., Poelstra, K., Ravnskjaer, K., Olinga, P. & Melgert, B. N., May-2020, In : Pharmaceutics. 12, 5, 21 p., 471.

    Research output: Contribution to journalArticleAcademicpeer-review

View all (165) »

Press / Media
  1. Proefdiervrij moet betrouwbaardere en waardevollere wetenschap opleveren

    Henri Leuvenink & Peter Olinga


    1 item of Media coverage

    Press/Media: Public Engagement ActivitiesProfessional

View all (1) »

  1. Human ex vivo models for liver disease

    Peter Olinga (Keynote speaker)


    Activity: Talk or presentationAcademic

  2. Drug targeting meets liver fibrosis

    Peter Olinga (Invited speaker)


    Activity: Talk or presentationAcademic

  3. Pharmacy Day

    Peter Olinga (Participant)


    Activity: Participating in or organising an eventParticipation in conferenceAcademic

View all (3) »

ID: 123591